Continuous Glucose Monitors in Diabetes Management | PTCE Pharmacy Connect

Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management   Objectives  Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data Faculty Disclosures Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose: Consultant: Bayer Speaker’s Bureau: Eli Lilly, NovoNordisk Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose: Speaker’s Bureau: Novo Nordisk, Inc. Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit. This activity is supported by an independent educational grant from Abbott Diabetes Care Inc. Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices